Lei Zhang's primary research focuses on cancer diagnostic biomarker development, using next-generation-sequencing, microarray, and other Omics technologies. His cutting edge work has introduced a new means for battling systemic cancers, i.e. saliva as a diagnostic tool that may aid in early detection. His original findings have been published in international peer-reviewed scientific journals. Five patents have been filed or granted internationally. Dr. Zhang, as the Principal Investigator, has been awarded grants from the California Breast Cancer Research Program and the Tobacco-Related Disease Research Program.  Lei Zhang's primary research focuses on cancer diagnostic biomarker development, using next-generation-sequencing, microarray, and other Omics technologies. His cutting edge work has introduced a new means for battling systemic cancers, i.e. saliva as a diagnostic tool that may aid in early detection. His original findings have been published in international peer-reviewed scientific journals. Five patents have been filed or granted internationally. Dr. Zhang, as the Principal Investigator, has been awarded grants from the California Breast Cancer Research Program and the Tobacco-Related Disease Research Program.

Biomarker